These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6422469

  • 1. Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide.
    Howell JN, Greene MH, Corner RC, Maher VM, McCormick JJ.
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1179-83. PubMed ID: 6422469
    [Abstract] [Full Text] [Related]

  • 2. Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma.
    Smith PJ, Greene MH, Adams D, Paterson MC.
    Carcinogenesis; 1983 Feb; 4(7):911-6. PubMed ID: 6409440
    [Abstract] [Full Text] [Related]

  • 3. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
    Sato K, Howell JN, Greene MH, Maher VM, McCormick JJ.
    Cancer Res; 1988 Sep 15; 48(18):5145-50. PubMed ID: 3136916
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
    Mirzayans R, Smith BP, Paterson MC.
    Cancer Res; 1989 Oct 15; 49(20):5523-9. PubMed ID: 2507129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Role of plasmids in providing the capacity for UV and 4NQO induced mutability in salmonellae].
    Skavronskaia AG, Andreeva IV, Kondrat'ev IuS, Aleshkin GI, Abdukhalykova GF.
    Dokl Akad Nauk SSSR; 1977 Oct 15; 236(2):460-3. PubMed ID: 410615
    [No Abstract] [Full Text] [Related]

  • 14. Reduced DNA repair capacity and increased cytotoxicity following split doses of the mutagen 4-nitroquinoline-1-oxide in cultured human cells.
    Warren PM, Stich HF.
    Mutat Res; 1975 May 15; 28(2):285-93. PubMed ID: 806012
    [Abstract] [Full Text] [Related]

  • 15. Hyperresistance to 4-nitroquinoline 1-oxide cytotoxicity and reduced DNA damage formation in dermal fibroblast strains derived from five members of a cancer-prone family.
    Mirzayans R, Sabour M, Rauth AM, Paterson MC.
    Br J Cancer; 1993 Nov 15; 68(5):838-44. PubMed ID: 8217598
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on chemical carcinogens. XXIV. Mutagenic potency of alkylated 4-nitroquinoline 1-oxides: its dependence on the rate of metabolic activation.
    Takahashi K, Kohda KH, Kawazoe Y.
    Chem Pharm Bull (Tokyo); 1983 Mar 15; 31(3):959-65. PubMed ID: 6411372
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.